2-5% of sales you say? So if Ellume sell 200m tests at US$15 per test that’s US$3B. I’ll take 2% of that for US$60m. PE of 20 and our MC is US$1.2B.
So since that’s what you think, I’m sure we’ll see 50c when we start trading again with the share price rising. That price doesn’t include our own saliva Covid test or our battery technology.
No doubt you will still be on the sidelines thinking 50c is over priced. Horse, water, whatever.
Ann: Trading Halt, page-72
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
